VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 89 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $4,154,000 | +120.8% | 327,352 | +61.9% | 0.02% | -7.7% |
| Q1 2015 | $1,881,000 | -53.1% | 202,216 | -27.8% | 0.03% | -61.8% |
| Q4 2014 | $4,010,000 | +124.4% | 280,000 | +62.6% | 0.07% | +83.8% |
| Q3 2014 | $1,787,000 | +123.4% | 172,161 | +248.0% | 0.04% | +105.6% |
| Q2 2014 | $800,000 | -51.5% | 49,466 | -67.1% | 0.02% | -73.1% |
| Q3 2013 | $1,648,000 | – | 150,500 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,525,476 | $74,263,000 | 4.09% |
| ARMISTICE CAPITAL, LLC | 2,828,000 | $46,407,000 | 2.68% |
| Birchview Capital, LP | 80,000 | $1,313,000 | 0.95% |
| GLOBEFLEX CAPITAL L P | 145,426 | $2,386,000 | 0.45% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 231,733 | $3,803,000 | 0.36% |
| 361 CAPITAL LLC | 77,630 | $1,274,000 | 0.35% |
| CADENCE CAPITAL MANAGEMENT LLC | 152,428 | $2,501,000 | 0.27% |
| BOOTHBAY FUND MANAGEMENT, LLC | 148,000 | $2,429,000 | 0.21% |
| EMERALD ADVISERS, LLC | 258,497 | $4,242,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 251,730 | $4,131,000 | 0.17% |